ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,853, issued on July 21, was assigned to UNIVERSITY OF MASSACHUSETTS (Westborough, Mass.).
"Methods and compositions for treatment of muscle disease with iPSC-induced human skeletal muscle stem cells" was invented by Charles P. Emerson (Lyndon, Vt.), Dongsheng Guo (Shrewsbury, Mass.), Katelyn M. Daman (Stow, Mass.), Jing Yan (Shrewsbury, Mass.), Jennifer Chee-Jen Chen (Kingston, Canada), Meng-jiao Shi (Shrewsbury, Mass.), Oliver D. King (Somerville, Mass.) and Lawrence J. Hayward (Sterling, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Human skeletal muscle stem cells were generated from facioscapulohumeral muscular dystrophy (FSHD) and health...